Hepatitis C  >>  PF-04136309  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PF-04136309 / Pfizer
NCT01226797: Safety And Efficacy Of Oral PF-4136309 In Patients With Chronic Hepatitis C Infection And Abnormal Liver Enzymes

Terminated
2
24
RoW
Placebo, PF-04136309
Pfizer
Hepatitis C, Chronic
02/12
02/12

Download Options